Intervention not reported
Number of participants who had additional self‐medication · Women undergoing excision of the cervical transformation zone for cervical neoplasia
It is very uncertain whether the intervention changes number of participants who had additional self‐medication (very low certainty).
1 finding from 1 review
Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility
It is very uncertain whether exposure to any ovary‐stimulating drugs for subfertility changes endometrial cancer compared with untreated subfertile women and endometrial cancer risk (very low certainty).
1 finding from 1 review
Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility
It is very uncertain whether exposure to any ovary‐stimulating drugs for subfertility changes endometrial cancer compared with general population and endometrial cancer risk (very low certainty).
1 finding from 1 review
Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility
It is very uncertain whether exposure to clomiphene citrate for subfertility changes endometrial cancer compared with untreated subfertile women and endometrial cancer risk (very low certainty).
1 finding from 1 review
Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility
It is very uncertain whether exposure to clomiphene citrate for subfertility changes endometrial cancer compared with general population and endometrial cancer risk (very low certainty).
1 finding from 1 review
Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility
It is very uncertain whether exposure to gonadotropins for subfertility changes endometrial cancer compared with untreated subfertile women and endometrial cancer risk (very low certainty).
1 finding from 1 review
Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility
It is very uncertain whether exposure to gonadotropins for subfertility changes endometrial cancer compared with general population and endometrial cancer risk (very low certainty).
1 finding from 1 review
Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility
It is very uncertain whether exposure to clomiphene citrate and gonadotropins for subfertility changes endometrial cancer compared with untreated subfertile women and endometrial cancer risk (very low certainty).
1 finding from 1 review
Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility
It is very uncertain whether exposure to clomiphene citrate and gonadotropins for subfertility changes endometrial cancer compared with general population and endometrial cancer risk (very low certainty).
1 finding from 1 review
Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility
It is very uncertain whether exposure to GnRH analogues for subfertility changes endometrial cancer compared with untreated subfertile women and endometrial cancer risk (very low certainty).
1 finding from 1 review
Intervention not reported
Overall Survival · Adults with recurrent GBM
1 finding from 1 review
Intervention not reported
Chemotherapy toxicity · Adults with recurrent GBM
1 finding from 1 review
Intervention not reported
Overall survival median · Adults with recurrent HGG
The intervention showed no clear difference in overall survival median (moderate certainty).
1 finding from 1 review
Intervention not reported
PFS Median · Adults with recurrent HGG
The intervention showed no clear difference in PFS Median (moderate certainty).
1 finding from 1 review
Intervention not reported
QoL EORTC QoL questionnaire C30; at baseline, 12 weeks and 24 weeks · Adults with recurrent HGG
1 finding from 1 review
Intervention not reported
Chemotherapy toxicity During 1st 12 weeks of treatment · Adults with recurrent HGG
1 finding from 1 review
Intervention not reported
PTB (< 37 w) · women with known obstetric outcomes
It is very uncertain whether the intervention changes PTB (< 37 w) (very low certainty).
1 finding from 1 review
Intervention not reported
LBW (< 2500 g) ‐ Treatment versus No Treatment · women with known obstetric outcomes
It is very uncertain whether the intervention changes LBW (< 2500 g) ‐ Treatment versus No Treatment (very low certainty).
1 finding from 1 review
Intervention not reported
NICU Admission ‐ Treatment versus No Treatment · women with known obstetric outcomes
The intervention may leads to higher NICU Admission ‐ Treatment versus No Treatment (low certainty).
1 finding from 1 review
Intervention not reported
Perinatal Mortality ‐ Treatment versus No Treatment · women with known obstetric outcomes
The intervention may leads to higher perinatal Mortality ‐ Treatment versus No Treatment (low certainty).
1 finding from 1 review